NIH grant supports Alpharose’s rosiphersen for Bain syndrome

Alpharose Therapeutics PBC has been awarded an NIH Small Business Innovation Research (SBIR) Fast Track grant to advance rosiphersen (ART-001), its lead antisense oligonucleotide therapy designed to treat Bain syndrome.